Patents Assigned to Precision Biologics
  • Monoclonal antibody therapy for pancreas cancer
    Patent number: 8470326
    Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: June 25, 2013
    Assignee: Precision Biologics
    Inventors: Myron Arlen, Kwong Tsang